Skip to content

Alamar Biosciences ALMR Financing Cash Flow

Financing Cash Flow at other companies

Nextra Energy logo
Nextra EnergyNEE
$7.68B+25.8%
UL Solutions logo
UL SolutionsULS
-$194M-43.7%
Boston Scientific logo
Boston ScientificBSX
-$260M-212%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
-$369.2M-164%
Atlassian logo
AtlassianTEAM
-$990.95M-638%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$530M-94.9%

Other financials

Income statement

See full
Revenue$26.0M+98.9%
Gross profit$14.5M+126%
Operating income-$12.3M-44.4%
Net income-$21.3M-178%
EPS (diluted)-$1.74-156%

Balance sheet

See full
Cash & equivalents$64.6M
Total debt$30.6M
Total equity-$178.1M
Total assets$186.5M

Cash flow

See full
Operating cash flow-$20.3M-55.7%
CapEx$600.0K+8.3%
Free cash flow-$20.9M-53.8%

Valuation

See full
Market cap$1.52B
Enterprise value$1.49B

Returns & leverage

See full
Debt / equity-0.2×
Current ratio5.9×

Where this comes from

Reported directly by Alamar Biosciences in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: Alamar Biosciences ’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alamar Biosciences 's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alamar Biosciences 's financing cash flow?
Alamar Biosciences (ALMR) reported financing cash flow of $55.76M in Q1 2026.
What does financing cash flow mean?
Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.